TARGETING THE ADENOSINERGIC IMMUNE SUPPRESSION PATHWAY IN HIGH GRADE GLIOMA SYNERGIZES WITH INNATE IMMUNE CHECKPOINT BLOCKADE

被引：0
|
作者：
Liu, Yifan [1 ]
Chetty, Senthil Lakshmana [2 ]
Cole, Allison [2 ]
Cruz, Joselyn Cruz [2 ]
Hoffmeyer, Eric [2 ]
Vibhakar, Rajeev [2 ]
Venkataraman, Sujatha [2 ]
Mitra, Siddhartha [2 ]
机构：
[1] Univ Colorado, Boulder, CO 80309 USA
[2] Univ Colorado, Sch Med, Aurora, CO USA
来源：
NEURO-ONCOLOGY | 2022年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IMMU-21
引用
收藏
页码：86 / 86
页数：1
相关论文
共 50 条
  • [1] TARGETING THE ADENOSINERGIC IMMUNE SUPPRESSION PATHWAY IN HIGH GRADE GLIOMA SYNERGIZES WITH INNATE IMMUNE CHECKPOINT BLOCKADE
    Chetty, Senthil Lakshmana
    Liu, Yifan
    Cole, Allison
    Cruz, Joselyn Cruz
    Hoffmeyer, Eric
    Vibhakar, Rajeev
    Venkataraman, Sujatha
    Mitra, Siddhartha
    NEURO-ONCOLOGY, 2022, 24 : 213 - 213
  • [2] COMBINATION OF MAPK PATHWAY INHIBITORS AND IMMUNE CHECKPOINT BLOCKADE IN BRAF-MUTANT HIGH-GRADE GLIOMA
    Park, Jong-Whi
    Grossauer, Stefan
    Wang, Wei
    Daynac, Mathieu
    Pitteri, Sharon
    Monje, Michelle
    Grant, Gerald
    Petritsch, Claudia
    NEURO-ONCOLOGY, 2021, 23 : 172 - 173
  • [3] Targeting microglial metabolic rewiring synergizes with immune checkpoint blockade therapy for glioblastoma
    Ye, Zengpanpan
    Ai, Xiaolin
    Zhao, Linjie
    Rich, Jeremy N.
    Zhou, Shengtao
    CANCER RESEARCH, 2023, 83 (08)
  • [4] Targeting Microglial Metabolic Rewiring Synergizes with Immune-Checkpoint Blockade Therapy for Glioblastoma
    Ye, Zengpanpan
    Ai, Xiaolin
    Yang, Kailin
    Yang, Zhengnan
    Fei, Fan
    Liao, Xiaoling
    Qiu, Zhixin
    Gimple, Ryan C.
    Yuan, Huairui
    Huang, Hao
    Gong, Yanqiu
    Xiao, Chaoxin
    Yue, Jing
    Huang, Liang
    Saulnier, Olivier
    Wang, Wei
    Zhang, Peidong
    Dai, Lunzhi
    Wang, Xin
    Wang, Xiuxing
    Ha Ahn, Young
    You, Chao
    Xu, Jianguo
    Wan, Xiaoxiao
    Taylor, Michael D.
    Zhao, Linjie
    Rich, Jeremy N.
    Zhou, Shengtao
    CANCER DISCOVERY, 2023, 13 (04) : 974 - 1001
  • [5] Lurbinectedin synergizes with immune checkpoint blockade to generate anticancer immunity
    Xie, Wei
    Forveille, Sabrina
    Iribarren, Kristina
    Sauvat, Allan
    Senovilla, Laura
    Wang, Yan
    Humeau, Juliette
    Perez-Lanzon, Maria
    Zhou, Heng
    Martinez-Leal, Juan F.
    Kroemer, Guido
    Kepp, Oliver
    ONCOIMMUNOLOGY, 2019, 8 (11):
  • [6] Targeting TIGIT: Strengthening the Immune Checkpoint Blockade
    Paz-Ares Rodriguez, Luis
    ONCOLOGY-NEW YORK, 2021, 35 (01): : 44 - 47
  • [7] The immune landscape of high-grade brain tumor after treatment with immune checkpoint blockade
    Park, Jang Hyun
    Kang, In
    Lee, Heung Kyu
    FRONTIERS IN IMMUNOLOGY, 2022, 13 : 1044544
  • [8] Antibody-mediated blockade of phosphatidylserine synergizes with immune checkpoint blockade by inhibiting multiple immune suppressive mechanisms
    Huang, Xianming
    Gong, Jian
    Gray, Michael
    Van Nguyen
    Parks, Ryan
    Hughes, Chris
    Hutchins, Jeff
    Brekken, Rolf
    Freimark, Bruce
    CANCER RESEARCH, 2016, 76
  • [9] Targeting Immune Suppressive Microenvironment By Immune Checkpoint Blockade in Multiple Myeloma
    Gorgun, Gullu Topal
    Cowens, Kristen
    Paula, Steven
    Samur, Mehmet Kemal
    Ohguchi, Hiroto
    Singh, Ahaana
    White, Randie E.
    Bianchi, Giada
    Suzuki, Rikio
    Kikuchi, Shohei
    Harada, Takeshi
    Mimura, Naoya
    Tai, Yu-Tzu
    Hideshima, Teru
    Laubach, Jacob P.
    Raje, Noopur
    Munshi, Nikhil C.
    Richardson, Paul G.
    Anderson, Kenneth C.
    BLOOD, 2014, 124 (21)
  • [10] High Grade Dermatologic Adverse Events Associated With Immune Checkpoint Blockade for Cancer
    Kuo, Alyce M.
    Markova, Alina
    FRONTIERS IN MEDICINE, 2022, 9
12345